AECOM (NYSE: ACM ) is a leading global infrastructure consulting company with approximately 51,000 technical experts and operations in over 50 countries. The company deals with large-scale projects in the environment, energy, transportation, and water, among other industries. The company operates more asAt Henriot Capital, we live by the principle that simplicity and common sense drive success. I’m passionate about building a hedge fund with a clear purpose, disciplined focus, and consistent alpha. Our appr ...

RBB Bancorp (RBB) Q1 2025 Earnings Call April 29, 2025 02:00 PM ET Company Participants David Morris - Director & CEOJohnny Lee - President & CEOLynn Hopkins - Executive VP & CFOBrendan Nosal - DirectorAndrew Terrell - Managing DirectorKelly Motta - MD - Equity ResearchTimothy Coffey - MD & Associate Director of Depository Research Conference Call Participants Rebeca Rico - AVP & Financial AnalystMatthew Clark - MD & Senior Research Analyst Operator Day, everyone, and welcome to the RBB Bancorp First Quarte ...

RBB Bancorp (RBB) Q1 2025 Earnings Call April 29, 2025 02:00 PM ET Company Participants David Morris - Director & CEOJohnny Lee - President & CEOLynn Hopkins - Executive VP & CFOBrendan Nosal - DirectorAndrew Terrell - Managing DirectorKelly Motta - MD - Equity ResearchTimothy Coffey - MD & Associate Director of Depository Research Conference Call Participants Rebeca Rico - AVP & Financial AnalystMatthew Clark - MD & Senior Research Analyst Operator Day, everyone, and welcome to the RBB Bancorp First Quarte ...

Flagstar Financial (FLG) Q1 2025 Earnings Call April 25, 2025 06:19 PM ET Company Participants Salvatore DiMartino - Executive VP & Director of Investor RelationsJoseph Otting - Executive Chairman, President & CEOLee Smith - Senior Executive Vice President & CFOMark Fitzgibbon - Head of FSG ResearchJared Shaw - Managing DirectorBen Gerlinger - Vice President of Equity ResearchChristopher Marinac - Director of ResearchChristopher Mcgratty - MD & Head of U.S. Bank ResearchEbrahim Poonawala - Managing Director ...

Gentherm (THRM) Q1 2025 Earnings Call April 24, 2025 08:00 AM ET Company Participants Gregory Blanchette - Senior Director, Investor RelationsBill Presley - President ,CEO & Board of DirectorJonathan Douyard - EVP, CFO & Treasurer Conference Call Participants Ryan Sigdahl - Partner & Senior Research AnalystNone - AnalystRyan Brinkman - Equity Research Analyst Operator Greetings and welcome to the Gentherm First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a list ...

Ally Financial Inc. (ALLY) Q1 2025 Earnings Conference Call April 17, 2025 07:30 AM ET Company Participants Operator - Conference Call Host/OperatorSean Leary - Head of Investor RelationsMichael Rhodes - CEORuss Hutchinson - CFOOperator - Q&A Facilitator Conference Call Participants Sanjay Sakrani - Analyst, KBWJeff Adelson - Analyst, Morgan StanleyRobert Wildhack - Analyst, Autonomous ResearchMoshe Orenburg - Analyst, TD CowanJohn Arfstrom - Analyst, RBC Capital Markets Operator Good day and thank you for ...

Financial Data and Key Metrics Changes - The company achieved high single-digit sales growth of 7% in Q1 2025, with adjusted earnings per share (EPS) growing 11% to $1.09, finishing at the high end of the guidance range [12][29][27] - Excluding COVID testing sales, sales growth was over 8% [12] - Gross margin expanded by 140 basis points, and operating margin increased by 130 basis points compared to the prior year [27][30] Business Line Data and Key Metrics Changes - Nutrition sales increased by 7%, driven by high single-digit growth in adult nutrition and double-digit growth in US pediatric nutrition [14] - Diagnostics sales declined by 5%, primarily due to a decrease in COVID-19 testing sales; core laboratory diagnostics grew 6.5% excluding China [15][29] - Established a new system, Alinity N, for molecular nucleic acid testing, representing a billion-dollar market opportunity [17] - Medical devices sales grew 12.5%, with continuous glucose monitors achieving over 20% growth [19] Market Data and Key Metrics Changes - Sales in the EPD segment increased by 8%, with double-digit growth in more than half of the key 15 markets [18] - The US dollar's weakening had a favorable impact on sales compared to exchange rates at the time of the previous earnings call [29] Company Strategy and Development Direction - The company is focused on navigating the complexities of a dynamic economic environment, including the impact of new tariff policies [10][11] - A diversified business model is emphasized as a strength, allowing the company to manage global challenges effectively [10] - The company plans to launch over 25 key new products over the next three years, contributing to sustained growth [27] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in maintaining guidance despite tariff impacts, estimating a few hundred million dollars in tariff-related costs for 2025 [45][46] - The company is actively assessing various scenarios to mitigate tariff impacts and is optimistic about its manufacturing network's flexibility [50][52] - Management expects the second half of 2025 to outperform the first half due to new product launches and improved market conditions [102] Other Important Information - The company is investing in R&D and expanding its portfolio in biosimilars and diagnostics, with a focus on enhancing its competitive position [18][90] - The company is also exploring M&A opportunities in medical devices and diagnostics while maintaining a disciplined approach to capital allocation [94][96] Q&A Session Summary Question: Impact of tariffs on full-year guidance - Management confirmed that tariffs will have a financial impact, estimating a few hundred million dollars for 2025, with a focus on mitigating strategies [45][46] Question: State of the EP franchise and Volt approval timeline - Management expressed optimism about the EP franchise, highlighting strong initial feedback for Volt and a potential US approval timeline in early 2026 [65][66] Question: Broader diagnostic strategy and M&A considerations - Management acknowledged challenges in the diagnostics segment, particularly in China, and emphasized the importance of M&A to enhance growth [82][90] Question: Acceleration of top-line growth in the second half - Management indicated that new product launches and favorable comparisons to previous year performance will drive growth acceleration [102][106] Question: Gross margin expectations amid tariff impacts - Management confirmed that tariffs would primarily affect gross margins, but favorable FX movements could help offset some impacts [108] Question: Plans for seeking exemptions from tariffs - Management stated that while they are engaged with industry associations, they do not rely on hope for tariff exemptions and are focused on data-driven strategies [130][132] Question: Diversified model and potential for unlocking value - Management reiterated the value of their diversified model and stated that they are continuously evaluating opportunities to create value without current plans for divestitures [138][140]

H.B. Fuller Company (FUL) Q1 2025 Earnings Call March 27, 2025 10:30 AM ET Company Participants Steven Brazones - Investor RelationsCeleste Mastin - President & Chief Executive OfficerJohn Corkrean - Executive VP & CFOKevin McCarthy - PartnerDavid Begleiter - Managing DirectorRachel Lee - Equity Research AssociateRosemarie Morbelli - Portfolio Manager Conference Call Participants Ghansham Panjabi - Senior Research AnalystMichael Harrison - Managing Director and Senior Chemicals AnalystJeffrey Zekauskas - An ...

Semtech Corporation (NASDAQ:SMTC) Q4 2025 Earnings Conference Call March 13, 2025 4:30 PM ET Company Participants Mark Lin - EVP & CFO Hong Hou - President & CEO Conference Call Participants Harsh Kumar - Piper Sandler Tim Arcuri - UBS Quinn Bolton - Needham and Co. Christopher Rolland - Susquehanna International Group Cody Acree - The Benchmark Company Kyle Smith - Stifel Operator Good day, and thank you for standing by. Welcome to Semtech Corporation's Fourth Quarter and Fiscal Year 2025 Earnings Conferen ...

John Wiley & Sons, Inc. (NYSE:WLY) Q3 2025 Earnings Conference Call March 6, 2025 10:00 AM ET Company Participants Brian Campbell - Vice President, Investor Relations Matt Kissner - President and CEO Christopher Caridi - Interim Chief Financial Officer Jay Flynn - Executive Vice President and General Manager, Research and Learning Conference Call Participants Daniel Moore - CJS Securities Sami Kassab - BNP Paribas Operator Good morning, and welcome to Wallace Q3 Fiscal 2025 Earnings Call. As a reminder, thi ...